Celularity Inc
For the period ended Dec 31, 2024. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 8, 2025
CELU$0.76-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
| Page | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 274) | 83 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) | 84 |
| Consolidated Balance Sheets | 85 |
| Consolidated Statements of Operations and Comprehensive Loss | 86 |
| Consolidated Statements of Stockholders’ Equity | 87 |
| Consolidated Statements of Cash Flow | 88 |
| Notes to Consolidated Financial Statements | 89 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.